iRhythm Holdings, Inc. IRTC Increase (decrease) in contract liabilities and current deferred income

Increase (decrease) in contract liabilities and current deferred income at other companies

ZymeworksZYME

-$340K+83.8%

GE HealthCare TechnologiesGEHC

——

Other financials

Income statement

See full

Revenue$199.4M+25.7%

Gross profit$141.4M+29.4%

Operating income-$16.2M+50.3%

Net income-$13.9M+54.6%

EPS (diluted)-$0.43+55.7%

Balance sheet

See full

Cash & equivalents$248.5M-35.2%

Total debt$79.0M-10.5%

Total equity$161.2M+86.0%

Total assets$1.0B+8.7%

Cash flow

See full

Operating cash flow-$26.2M-232%

CapEx$6.9M-26.7%

Free cash flow-$33.1M-91.1%

Valuation

See full

Market cap$3.7B-20.6%

Enterprise value$3.53B-19.1%

P/S4.7×-2.8×

Profitability

See full

Gross margin71%+1.6pp

Operating margin-5.5%-2.2pp

Net margin-7.3%-3.1pp

FCF margin2.4%—

Returns & leverage

See full

Return on equity-53.1%-17.4pp

Debt / equity0.5×-0.5×

Current ratio5.2×-0.5×

Where this comes from

Reported directly by iRhythm Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInContractWithCustomerLiability.

The official record: iRhythm Holdings, Inc. ’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about iRhythm Holdings, Inc. 's increase (decrease) in contract liabilities and current deferred income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is iRhythm Holdings, Inc. 's increase (decrease) in contract liabilities and current deferred income?: iRhythm Holdings, Inc. (IRTC) reported increase (decrease) in contract liabilities and current deferred income of -$145K in Q1 2026.
How has iRhythm Holdings, Inc. 's increase (decrease) in contract liabilities and current deferred income changed year-over-year?: iRhythm Holdings, Inc. 's increase (decrease) in contract liabilities and current deferred income decreased by 141.4% year-over-year, from $350K to -$145K.